142 related articles for article (PubMed ID: 36893559)
1. Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells.
Shui Y; Hu X; Hirano H; Tsukamoto H; Guo WZ; Hasumi K; Ijima F; Fujino M; Li XK
Neoplasia; 2023 May; 39():100893. PubMed ID: 36893559
[TBL] [Abstract][Full Text] [Related]
2. β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells.
Shui Y; Hu X; Hirano H; Kusano K; Tsukamoto H; Li M; Hasumi K; Guo WZ; Li XK
Int Immunopharmacol; 2021 Dec; 101(Pt A):108265. PubMed ID: 34715491
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
4. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
5. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
[TBL] [Abstract][Full Text] [Related]
6. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
7. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
8. A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation.
Wang Y; Huang H; Yao S; Li G; Xu C; Ye Y; Gui S
J Ethnopharmacol; 2019 Sep; 241():111980. PubMed ID: 31146000
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses.
Jin JO; Zhang W; Du JY; Wong KW; Oda T; Yu Q
PLoS One; 2014; 9(6):e99396. PubMed ID: 24911024
[TBL] [Abstract][Full Text] [Related]
10. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
11. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).
Ghoneum M; Agrawal S
Int J Immunopathol Pharmacol; 2011; 24(4):941-8. PubMed ID: 22230400
[TBL] [Abstract][Full Text] [Related]
12. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
Repnik U; Bergant M; Wraber B; Jeras M
Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
[TBL] [Abstract][Full Text] [Related]
13. ATP and its metabolite adenosine cooperatively upregulate the antigen-presenting molecules on dendritic cells leading to IFN-γ production by T cells.
Furuta K; Onishi H; Ikada Y; Masaki K; Tanaka S; Kaito C
J Biol Chem; 2023 Apr; 299(4):104587. PubMed ID: 36889584
[TBL] [Abstract][Full Text] [Related]
14. The influence of physical activity in the anti-tumor immune response in experimental breast tumor.
Bianco TM; Abdalla DR; Desidério CS; Thys S; Simoens C; Bogers JP; Murta EFC; Michelin MA
Immunol Lett; 2017 Oct; 190():148-158. PubMed ID: 28818640
[TBL] [Abstract][Full Text] [Related]
15.
Wei W; Mu S; Han Y; Chen Y; Kuang Z; Wu X; Luo Y; Tong C; Zhang Y; Yang Y; Song Z
Front Immunol; 2022; 13():841254. PubMed ID: 35669778
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions.
Falcón-Beas C; Tittarelli A; Mora-Bau G; Tempio F; Pérez C; Hevia D; Behrens C; Flores I; Falcón-Beas F; Garrido P; Ascui G; Pereda C; González FE; Salazar-Onfray F; López MN
Immunobiology; 2019 Sep; 224(5):697-705. PubMed ID: 31221438
[TBL] [Abstract][Full Text] [Related]
17. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
[TBL] [Abstract][Full Text] [Related]
18. Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.
Engel AL; Sun GC; Gad E; Rastetter LR; Strobe K; Yang Y; Dang Y; Disis ML; Lu H
Immunobiology; 2013 Dec; 218(12):1468-76. PubMed ID: 23735481
[TBL] [Abstract][Full Text] [Related]
19. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
[TBL] [Abstract][Full Text] [Related]
20. Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells.
Acharya AP; Dolgova NV; Xia CQ; Clare-Salzler MJ; Keselowsky BG
Acta Biomater; 2011 Jan; 7(1):180-92. PubMed ID: 20807596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
